SEC Comment Letter for PRECIGEN, (PGEN) — Mar 5, 2026

PRECIGEN, INC.
Date: March 5, 2026 · CIK: 0001356090 · Accession: 0000000000-26-002284

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36042

Date

March 5, 2026

Author

Harry Thomasian Jr.

Form

UPLOAD

Company

PRECIGEN, INC.

Letter

March 5, 2026 Harry Thomasian Jr. Chief Financial Officer Precigen, Inc. 20374 Seneca Meadows Parkway Germantown, MD 20876 Re:Precigen, Inc. Form 10-K for the fiscal year ended December 31, 2024 File No. 001-36042 Dear Harry Thomasian Jr.: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

March 5, 2026
Harry Thomasian Jr.
Chief Financial Officer
Precigen, Inc.
20374 Seneca Meadows Parkway
Germantown, MD 20876
Re:Precigen, Inc.
Form 10-K for the fiscal year ended December 31, 2024
File No. 001-36042
Dear Harry Thomasian Jr.:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io